Table 4.
Comparison of AROC values on HLA-DRB1*0401 data sets from MHCBench
| Method | Set1 | Set2 | Set3a | Set3b | Set4a | Set4b | Set5a | Set5b | Avg. |
| TEPITOPE | 0.776 | 0.740 | 0.740 | 0.754 | 0.763 | 0.750 | 0.651 | 0.661 | 0.729 |
| PERUN | 0.771 | 0.685 | 0.693 | 0.713 | 0.724 | 0.672 | 0.695 | 0.714 | 0.708 |
| Gibbs Sampler2 | 0.803 | 0.775 | 0.75 | 0.762 | 0.793 | 0.787 | 0.6211 | 0.6611 | 0.744 |
| LP_top22 | 0.725 | 0.721 | 0.728 | 0.753 | 0.719 | 0.728 | 0.8151 | 0.8591 | 0.756 |
| SKM | 0.870 | 0.832 | 0.823 | 0.821 | 0.862 | 0.827 | 0.787 | 0.770 | 0.824 |
Comparing performance of SKM with results reported for the Gibbs Sampling method [27], "LP_top2" [21], and PERUN [7]. Best results shown in bold.
1: Best reported results, where Cysteines are treated as Alanines [27].
2: Best reported results of [21].
Results of the LP_top2 and Gibbs Sampler are from evaluation on the MHCBench sets. However, as is described in [21], training was performed on a training set consisting of selected samples from MHCPEP [1] and SYFPEITHI [53]. However, MHCBench mainly consists of samples from MHCPEP, and a large overlap exist between training and test sets (e.g. 502 of 646 samples of Set 4a).